In vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina

Asian Pacific Journal of Tropical Biomedicine

Volumn 4, Issue , 2014, Pages S455-S459

  Sivajothi, Vaiyapuri ^a   Dakappa, Shruthi Shirur ^b  

^a Oxford College of Pharmacy   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

4 Oxo 4H pyran 2; 6 dicarboxylic acid bis 6 methyl heptyl ester; AMP kinese; Cheick embryo; Tragia cannabina

Indexed keywords

4 OXO 4H PYRAN 2,6 DICARBOXYLIC ACID BIS(6 METHYLHEPTYL)ESTER; ADENYLATE KINASE; ALCOHOL; ANTIDIABETIC AGENT; CHLOROFORM; FLAVONOID; INSULIN; METFORMIN; PLANT EXTRACT; PLANT GLYCOSIDE; PYRAN DERIVATIVE; SAPONIN; TANNIN DERIVATIVE; TRAGIA CANNABINA EXTRACT; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; EMBRYO; ENZYME ACTIVATION; EUPHORBIACEAE; GLUCOSE BLOOD LEVEL; HYDROGEN BOND; IN VITRO STUDY; LEGHORN CHICKEN; MOLECULAR DOCKING; NONHUMAN; PLANT ROOT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRAGIA CANNABINA;

TRAGIA;

EID: 84922638244     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.12980/APJTB.4.2014C1049     Document Type: Article

References (27)

1. Council of Scientific & Industrial Research. The wealth of India. Vol. X: A dictionary of Indian raw materials and industrial products. New Delhi: Publication and information directorate, CSIR; 1998, p. 272.
2. Nadkarni KM. Indian materia medica. Bombay, India: Popular Book Depot; 1976, p. 1226.
3. Reddy KN, Trimurthulu G, Sudhakar Reddy C. Plants used by the ethnic people of Krishna district, Andhra Pradesh. Indian J Tradit Knowl 2010; 9: 313-317.
4. Sivajothi V, Dey A, Jayakar B, Rajkapoor B. Antihyperglycemic property of Tragia cannabina in streptozotocin-induced diabetic rats. J Med Food 2007; 10: 361-365.
5. Balandrin MF, Kinghorn AD, Farnsworth NR. Human medicinal agents from plants, ACS symposium series 534. Washington, DC: NPS Pharmaceuticals, Inc.; 1993, p. 48.
6. Kirtikar KR, Basu BD. Indian medicinal plants. Bahadurganj, India: Sudhindra Nath Basu, Pâninî office; 2002, p. 2190-2191.
7. Balandrin MF, Kinghorn AD, Farnsworth NR. Human medicinal agents from plants, ACS symposium series 534. Washington, DC: NPS Pharmaceuticals, Inc.; 1993, p. 2.
8. Patel RK, Patel SB, Shah JG. Evaluation of acute and subacute toxicity of alcoholic extract of the roots of Tragia cannabina in rats. Int J Pharm Sci Res 2012; 3: 479-482.
9. Chehade JM, Mooradian AD. A rational approach to drug therapy of type 2 diabetes mellitus. Drugs 2000; 60: 95-113.
10. Pradeepa R, Deepa R, Mohan V. Epidemiology of diabetes in India-current perspective and future projections. J Indian Med Assoc 2002; 100: 144-148.
11. Kavi Kishor PB, Sangam S, Amrutha RN, Sri Laxmi P, Naidu KR, Rao KRSS, et al. Regulation of proline biosynthesis, degradation, uptake and transport in higher plants: Its implication in plant growth and abiotic stress tolerance. Curr Sci 2005; 88: 424-438.
12. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011; 25: 1895-1908.
13. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999; 24: 22-25.
14. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated protein kinase subfamily. J BiolChem 1996; 271: 611-614.
15. Frøsig C, Pehmøller C, Birk JB, Richter EA, Wojtaszewski JF. Exercise-induced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. J Physiol 2010; 588: 4539-4548.
16. Srivastava RA, Pinkosky SL, Filippov S, Hanselman JC, Cramer CT, Newton RS. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res 2012; 53: 2490-2514.
17. Hardie DG, Ross FA, Hawley SA. AMP-activated protein kinase: a target for drugs both ancient and modern. Chem Biol 2012; 19: 1222-1236.
18. Harborne JB. Phytochemical methods. London: Chapman and Hall Ltd; 1973, p. 49-188.
19. Alenzi FQ. Effect of Nicotinamide on experimental induced diabetes. Iran J Allergy Asthma Immunol 2009; 8: 11-18.
20. Yoshiyama Y, Kanke M. Toxic interactions between fluconazole and disopyramide in chick embryos. Biol Pharm Bull 2005; 28: 151-153.
21. Datar SP, Bhonde RR. Modeling chick to assess diabetes pathogenesis and treatment. Rev Diabet Stud 2011; 8: 245-253.
22. Maheshwari P, Baburao B, Pradeep Kumar Ch, Rama Narsimha Reddy A. Antidiabetic activity of methanolic extract of Hiptage bengalensis leaves in alloxan induced diabetic models. Pak J Biol Sci 2013; 16(17): 844-851.
23. Binkowski TA, Naghibzadeg S, Liang J. CASTp: computed atlas of surface topography of proteins. Nucleic Acid Res 2003; 31: 3352-3355.
24. Vidya SM, Krishna V, Manjunatha BK, Rajesh KP, Bharath BR, Manjunatha H. Antibacterial and molecular docking studies of entagenic acid, a bioactive principle from seed kernel of Entada pursaetha DC. Med Chem Res 2012; 21: 1016-1022.
25. Shruthi SD, Padmalatha Rai S, Ramachandra YL. Isolation, characterization, antibacterial, antihelminthic, and In silico studies of polyprenol from Kirganelia reticulata Baill. Med Chem Res 2013; 22: 2938-2945.
26. Annapurna HV1, Apoorva B, Ravichandran N, Arun KP, Brindha P, Swaminathan S, et al. Isolation and in silico evaluation of antidiabetic molecules of Cynodon dactylon (L.). J Mol Graph Modell 2013; 39: 87-97.
27. Rodriguez A, Infante D. Characterization in silico of flavonoids biosynthesis in Theobroma cacao L. Network Biol 2011; 1: 34-45.